Allena Pharmaceuticals Inc

Allena Pharmaceuticals Inc is an American company focused on developing oral enzyme therapeutics for metabolic and kidney disorders. Operating in the US, its primary aim is to address conditions driven by excessive endogenous or dietary metabolites, such as hyperoxaluria, through innovative therapies operating within the biopharmaceutical space. Operating within the biopharmaceutical sector, Allena Pharmaceuticals Inc concentrates on using novel enzyme-based approaches delivered orally. The company aims to provide non-systemic treatments that could potentially improve outcomes for patients with specific metabolic or kidney conditions by reducing metabolite levels in the digestive tract. Keep up to date on the latest share price changes by adding ALNA stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.